Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2008
11/27/2008WO2008142859A1 Novel spiro-oxindole compound and pharmaceutical containing the same
11/27/2008WO2008142702A1 A synergistic ayurvedic / functional food bioactive composition [cincata]
11/27/2008WO2008142460A2 New herbal composition for prevention and treatmant of diabetes melitusa of type (i) and type (ii)
11/27/2008WO2008142454A1 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders
11/27/2008WO2008142319A2 Peptide analogues of melanocortin receptors
11/27/2008WO2008141480A1 Human angiostatin interacting and tumor metastasis involving protein variants and uses thereof
11/27/2008WO2008141455A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/27/2008WO2008112651A3 Aminopyrimidines useful as inhibitors of protein kinases
11/27/2008WO2008101723A3 Pharmaceutical composition containing a cholesterol absorption inhibitor
11/27/2008WO2008087365A3 Substituted 1, 3-diphenylpropane derivatives, preparations and uses of same
11/27/2008WO2008077145A3 Treatment of il-1-beta related diseases
11/27/2008WO2008066664A3 Cis-cyclohexyl substituted pyrimidinone derivatives
11/27/2008WO2008061671A3 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
11/27/2008WO2008046087A3 Spiro compounds and their uses as therapeutic agents
11/27/2008WO2008024438A3 2-phenoxy pyrimidinone analogues
11/27/2008US20080293949 Novel heterocyclic analogs of diphenylethylene compounds
11/27/2008US20080293830 Method For Activating Efferent Sympathetic Nerves Innervating Adipose Tissues To Improve Obesity And Symptoms Associated Therewith
11/27/2008US20080293822 Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use
11/27/2008US20080293818 Regulator of Physiological Function of Ghrelin and Use Thereof
11/27/2008US20080293815 Hca for improved hdl serum lipids profile
11/27/2008US20080293801 Solid Amorphous Dispersions of An Mtp Inhibitor For Treatment of Obesity
11/27/2008US20080293794 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof
11/27/2008US20080293792 (R)-2-(9-(1H-imidazol-1-yl)nonyl)-2,5,7,8-tetramethylchroman-6-ol, capable of inhibiting tocopherol-omega-hydroxylase, responsible for the metabolism of tocopherol and tocotrienol compounds of vitamin E, and thus increase the amount and prolong the bioavailability of these compounds in plasma and tissue
11/27/2008US20080293791 Valsartan salts
11/27/2008US20080293785 Substituted benzothiazole kinase inhibitors
11/27/2008US20080293782 1,1,3-Trioxo-1,2,5-Thiadiazolidines and Their Use as Ptp-Ases Inhibitors
11/27/2008US20080293780 Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use
11/27/2008US20080293777 Weight Loss Treatment
11/27/2008US20080293776 1,2,5-Thiazolidine Derivatives Useful for Treating Conditions Mediated by Protein Tyrosine Phosphatases (Ptpase)
11/27/2008US20080293772 Salts of picotamide
11/27/2008US20080293767 1-Isopropyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide Derivatives Having 5-Ht4 Receptor Agonistic Activity
11/27/2008US20080293765 Alkylsulphonamide Quinolines
11/27/2008US20080293761 Pyrrolopyridine-2-Carboxylic Acid Amide Derivative Useful as Inhibitor of Glycogen Phosphorylase
11/27/2008US20080293741 Tricyclo Substituted Amides as Glucokinase Modulators
11/27/2008US20080293735 Administering a dopamine/norepinephrine neuronal activity ratio-increasing therapeutic such as GBR 12909 Vanoxerine, (1-(2-[bis(4-Fluorophenyl)methoxy]ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride), a specific dopamine reuptake inhibitor
11/27/2008US20080293713 Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme
11/27/2008US20080293694 New compounds
11/27/2008US20080293690 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
11/27/2008US20080293671 Combination of Polychitosamine and Fibrate for the Prevention and Treatment of Hyperlipidemia
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293644 Guava extract
11/27/2008US20080293642 C-Glycosylisoflavones Having Alkylaminoalkoxyl Substituent, Preparation and Use of the Same
11/27/2008US20080293631 Treatment for Autoimmune and Inflammatory Conditions
11/27/2008US20080293629 Albumin Fusion Proteins
11/27/2008US20080293626 Pigment epithelium-derived factor as a therapeutic agent for vascular leakage
11/27/2008US20080293618 Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors
11/27/2008US20080293163 Methods to identify compounds that modulate rage
11/27/2008US20080292719 Method of Treating Metabolic Syndrome
11/27/2008US20080292718 Method for Suppression Appetite and Food Intake
11/27/2008US20080292707 Pharmaceutical Compositions of Adsorbates of Amorphous Drug
11/27/2008US20080292700 Controlled release formulations using intelligent polymers
11/27/2008US20080292697 Direct compression polymer tablet core
11/27/2008US20080292691 Bariatric magnetic apparatus and method of manufacturing thereof
11/27/2008US20080292649 Composition for improving membrane composition and functioning of cells
11/27/2008US20080292642 Crystalline anti-human IL-12 antibodies
11/27/2008US20080292640 Methods for the treatment of il-1beta related diseases
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292613 Food Supplement Based on Group B Vitamins, Trace Elements and -3 and/or 6- Fatty Acids and Use of This Food Supplement in the Simultaneous Treatment of Localized Cellulite and Slackening of the Skin
11/27/2008US20080292608 Compounds and Compositions as Ppar Modulators
11/27/2008US20080292581 Interleukin-11 Fusion Proteins
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2687338A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/26/2008EP1995243A1 Triazole derivative or salt thereof
11/26/2008EP1994837A2 Plant derived or derivable material with appetite suppressant activity
11/26/2008EP1994031A1 Use of adenosine a1 and/or dual a1/a2b agonists for production of medicaments for treating diseases
11/26/2008EP1993559A2 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
11/26/2008EP1993558A2 Oxysterol compounds and the hedgehog pathway
11/26/2008EP1993530A2 Use of dha and ara in the preparation of a composition for regulating gene expression
11/26/2008EP1993522A2 Resveratrol and/or grape leaf extract as i.a. endurance improver, anti-aging agent, muscle strength improver
11/26/2008EP1756084B1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/26/2008EP1740568B1 Benzofuran and benzothiophene derivatives useful for the treatment of cardiovascular disease.
11/26/2008EP1594492B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/26/2008EP1534707B9 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/26/2008EP1502596B1 Herbal product to be administered to diabetic individuals and the production method thereof
11/26/2008EP1496914B1 (20S)-1alpha-HYDROXY-2alpha-METHYL AND 2beta-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
11/26/2008EP1480642B1 Peroxisome proliferator activated receptor modulators
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008EP1419173B1 Peptides that bind to atherosclerotic lesions
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1381382B1 Methods and compositions for the treatment of diseases of the eye
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1155015B1 Process for the production of tert-butyl (e)-(6-¬2-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino pyrimidin-5-yl vinyl (4r,6s)-2,2-dimethyl¬1,3 dioxan-4-yl)acetate
11/26/2008EP1153609B1 Amino acid-containing albumin preparations
11/26/2008CN101313066A Modulation of glucocorticoid receptor expression
11/26/2008CN101312969A Azaindole-2-carboxamide derivatives
11/26/2008CN101312963A Glucagon receptor antagonists, preparation and therapeutic uses
11/26/2008CN101312961A Isoquinoline and benzo[H]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of the histamine h3 receptor
11/26/2008CN101312957A 1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (ptpase)
11/26/2008CN101312952A Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
11/26/2008CN101312940A Glucagon receptor antagonists, preparation and therapeutic uses
11/26/2008CN101312746A Preparation containing iron(iii)-complexes and redox substances
11/26/2008CN101312735A Combination of polychitosamine and fibrate for the prevention and treatment of hyperlipidemia
11/26/2008CN101312726A Hexahydro cyclooctyl pyrazole cannabinoid modulators
11/26/2008CN101312725A Hexahydro cyclooctyl pyrazole cannabinoid modulators
11/26/2008CN101312724A Tetrahydro-indazolyl cannabinoid modulators
11/26/2008CN101312723A Glucagon receptor antagonists, preparation and therapeutic uses
11/26/2008CN101312722A Modulators of atp-binding cassette transporters
11/26/2008CN101312661A Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses
11/26/2008CN101312660A High-potency sweetener for weight management and compositions sweetened therewith
11/26/2008CN101311175A New xanthones compounds, preparation method and use thereof
1 ... 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 ... 1298